APA (7th ed.) Citation

AVM, B., CW, D., JC, J., S, K., FL, C., RJ, S., . . . CL, Z. (2025). Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: A protocol for randomised controlled multicentre phase III trial, the SOUND trial. BMJ open, 15(12), e107101. https://doi.org/10.1136/bmjopen-2025-107101

Chicago Style (17th ed.) Citation

AVM, Burger, et al. "Transtympanic Sodium Thiosulphate to Prevent Cisplatin-related Hearing Loss: A Protocol for Randomised Controlled Multicentre Phase III Trial, the SOUND Trial." BMJ Open 15, no. 12 (2025): e107101. https://doi.org/10.1136/bmjopen-2025-107101.

MLA (9th ed.) Citation

AVM, Burger, et al. "Transtympanic Sodium Thiosulphate to Prevent Cisplatin-related Hearing Loss: A Protocol for Randomised Controlled Multicentre Phase III Trial, the SOUND Trial." BMJ Open, vol. 15, no. 12, 2025, p. e107101, https://doi.org/10.1136/bmjopen-2025-107101.